1) The document discusses good practices for dispensing and sampling of raw materials in pharmaceutical manufacturing. It emphasizes carefully following standard operating procedures to prevent contamination.
2) Key steps in dispensing include cleaning the room, checking that the right chemical and amount are issued, weighing while being double checked, and immediately cleaning up any dust.
3) Tips to prevent contamination include sampling one material at a time in a segregated booth, cleaning all containers before storage, having appropriate air control systems, and avoiding simultaneous charging of raw materials for different batches.
In this slide contains Calibration vs Qualification and phases of qualification.
Presented by: A.Siddartha Tharun Teja. (Department of industrial pharmacy).
RIPER, anantapur.
Validation: Validation is a documented program that provides high degree of assurance that a specific process, method or system consistently produces a result meeting pre-determined acceptance criteria.
In this slide contains Calibration vs Qualification and phases of qualification.
Presented by: A.Siddartha Tharun Teja. (Department of industrial pharmacy).
RIPER, anantapur.
Validation: Validation is a documented program that provides high degree of assurance that a specific process, method or system consistently produces a result meeting pre-determined acceptance criteria.
The presentation deals with the hot issues of regulatory violations made by the Ranbaxy in Mohali plant. It has the violations made and the observations of the FDA inspector, also gives a basic overview of what is form 483 and consent decree. The CAPA I will be uploading soon enough.
In this slide contains definition and details of Qualification Of HPLC
Presented by: KHALID KUWAITY (Department of pharmaceutical analysis).RIPER, anantapur
Analytical method validation as per ich and usp shreyas B R
Analytical method validation is a process of documenting/ proving that an analytical method provides analytical data acceptable for the intended use.After the development of an analytical procedure, it is must important to assure that the procedure will consistently produce the intended a precise result with high degree of accuracy. The method should give a specific result that may not be affected by external matters. This creates a requirement to validate the analytical procedures. The validation procedures consists of some characteristics parameters that makes the method acceptable with addition of statistical tools.
Validation by Vilegave Kailash, Shivajirao S. Jondhle college of Pharmacy Asa...Kailash Vilegave
General aspects
Validation of parenterals
Validation of tablets
component of validation,function of different departments,reasons for validation,shivajirao s jondhle college of pharmacy asangaon,validation of parenterals,validation of tablets,validation priority,vilegave kailash
The presentation deals with the hot issues of regulatory violations made by the Ranbaxy in Mohali plant. It has the violations made and the observations of the FDA inspector, also gives a basic overview of what is form 483 and consent decree. The CAPA I will be uploading soon enough.
In this slide contains definition and details of Qualification Of HPLC
Presented by: KHALID KUWAITY (Department of pharmaceutical analysis).RIPER, anantapur
Analytical method validation as per ich and usp shreyas B R
Analytical method validation is a process of documenting/ proving that an analytical method provides analytical data acceptable for the intended use.After the development of an analytical procedure, it is must important to assure that the procedure will consistently produce the intended a precise result with high degree of accuracy. The method should give a specific result that may not be affected by external matters. This creates a requirement to validate the analytical procedures. The validation procedures consists of some characteristics parameters that makes the method acceptable with addition of statistical tools.
Validation by Vilegave Kailash, Shivajirao S. Jondhle college of Pharmacy Asa...Kailash Vilegave
General aspects
Validation of parenterals
Validation of tablets
component of validation,function of different departments,reasons for validation,shivajirao s jondhle college of pharmacy asangaon,validation of parenterals,validation of tablets,validation priority,vilegave kailash
Aseptic / sterile - “ A state of control attained by using an aseptic work area and performing activities in a manner that precludes microbiological contamination of the exposed sterile product”
Validation of aseptic process should be designed to provide assurance through appropriate testing that all phases and activities of the process remain sterile and it is controlled within the predetermined parameters.
Drug product, container, and closure are subject to sterilization separately, and then brought together.
A short presentation on containments which is used for potent drug manufacturing facilities and labs also these are used in biotechnology industries.
Very useful for BSL facility and Oncology/Hormones/Esteroids manufacturing and research.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
2. Good Dispensing and
Sampling Practices
Saffron Pharmaceuticals (Pvt.) Ltd.
19 Km. Sheikhupura Road, Faisalabad-Pakistan.
• Presented by:
Dr. Yasir Mehmood
PhD Pharmaceutics,
MBA (Health
management)
• Head QA & VIRAC
3. Dispensing of Raw Materials
Dispensing the right materials to the right batches prior to
the manufacturing process is a key activity in life sciences and other process
industries. The process is critical when working with potent active pharmaceutical
ingredients (APIs) in
drug manufacturing.
“
“
4. Steps of dispensing out
starting material
After weighing there will be dust that must
be cleaned up immediately according to
paper work
4-Clean up
Take particular care and double check that
the right chemical, the right lot and right
amount are weighed
3-Weighing
Take particular care and double check that
the right chemical, the right lot and batch
no. has been issued by the weare house
against a paper
2- Setup
1-Room
clearance
Removal of all previous contaminations
and make the room clean for next batch
5. Contamination control
in Dispensing area
Dispensing of the material should be done carefully under the dispensing booth
to protect the material from contamination. Dispensing equipment must be
cleaned and free from contamination. The SOPs for the dispensing materials
needs to be carefully followed to prevent any cross contamination
6. Tips to prevent pharmaceutical contamination
2- Sampling in a segregated
cubicle/booth fitted with
suitable air control systems.
7- Simultaneous charging & loading of
raw materials for two different batches,
two different stages and two different
products should be avoided
1- Sample only one material
at a time
4- All containers packaged
must be effectively cleaned
before these are admitted to
the storage area
5- Evolve and follow suitable
equipment cleaning procedures.
Periodically validate them to confirm
the effectiveness
8- During the change over single
individual impurity is not more than 0.1%
(1000 PPM). Total impurity is not more
than 0.5% (5000 PPM).
1
3
4
5
7
8
2
6
3- Dispensing stations must be
equipped with suitable dust
extraction system
6- Air supply systems for the
production and dispensing areas must
be designed to avoid contamination
into the airflow (or) to the
manufacturing areas
7. cleaning and validation of dispensing area
2
1
6
5
4 3
Dispensing & sampling
room is to be cleaned at
the time of every
product change over &
after every sampling
Previous dispensed product
/sampled material container
and dispensing/sampling
equipment are removed from
the dispensing and sampling
area
Remove the powder from floor
and powder from the outer
surface of RLAF pre filter frame,
return riser filter and side panel
by using a vacuum cleaner.
Mop the entire surface of
pre-filter frames, return
riser filter and side panel &
Clean the Stainless Steel
Table and Balances
Dispensing/Sampling
Room floor shall be
cleaned as per schedule at
the beginning and
completion of work
Store person shall close the
polythene bags inside the waste
bin and send it to scrap yard &
Store person record the cleaning
activity in Dispensing Logbook
8. Equipment Wash and Preparation
Small items such as scoops, small c
ontainers and sample thiefs can be
cleaned in a specifically designed w
ashroom or within the weighing roo
m.
Larger equipment, such as pails,
drums and small IBCs (holding less
than 100 liters), are usually cycled thr
ough the manufacturing washroom
Large IBCs, particularly those above
1,000 liters, are normally cleaned with
Clean-In-Place systems, in
which spray balls are inserted through
the top opening
01
02
03
03
06
9. Health and safety
4
The sample storage
areas should have
adequate light and
ventilation
3
The sampler should have
safe access to and egress
from the place where the
sample is taken, and the
places where the samples
are taken for storage
1
Sampler should
wear appropriate
protective
clothing for the
task
2
If specific safety
precautions are
required, such as the
use of respiratory
equipment, the sampler
should be properly
trained in its use
10. Category II: <100 mcg/m3 -
>20 mcg/m3
This is the first category that
requires the use of special
equipment to create an additional
separation like laminar flow booth
between the operator and the
materials being handled
Category IV: <1 mcg/m3
Below the 1 mcg/m3 level, we have
reached the guaranteed limits of SBVs
and must look to isolation technology
to meet this containment requirement.
This includes the use of glove boxes
with rapid transfer ports (RTP).
Category I: >100 mcg/m3
At this level, following normal
cGMP is usually enough
protection for an operator
Category III: <20 mcg/m3 –
>1 mcg/m3
At this point, we have reached the
lower level of the capabilities of
laminar flow technology and another
level of control must be applied like
Split butterfly valves (SBV)
Specialized Suites – Potent Compounds
11. Warehouse Waste Move
ment
Non-hazardous solid waste (i.e., paper, cartons,
plastic, etc.) generated in the weighing area is
collected in plastic bins and transferred via a
dumpster to a waste compactor. All contaminated
solid waste should be disposed of in accordance with
hazardous material regulations
17. Definition
Accuracy
Closeness of agreem
ent between a measu
red quantity value an
d a true quantity valu
e of a measured. VI
M .
Trueness
closeness of agreement
between the average of
an infinite number of r
eplicate measured quan
tity values and a referen
ce quantity value
Precision
Closeness of agreement
between indications or
measured quantity value
s obtained by replicate
measurements on the sa
me or similar objects un
der specified conditions.
VIM
18. 18
Imprecisely, accurately
(values are wide-spread)
Imprecisely, accurately
(values are wide-spread)
Precise, inaccurately (good
balance repeatability) Balance
accuracy and precision
Precise, accurately (good
balance repeatability)
Accuracy & Precision
19. 19
REPEATABILITY USP General Chapter <41>
Repeatability tolerance 0.10%
Expansion factor, K 2
Acceptance criteria 2 x SD/N ≤ 0.10%
Smallest possible sample weight/lowest
starting point
820 d (in optimal conditions)
Operating Range (2 x SD x 1000) to max capacity or
(2 x 0.41d x 1000) to max capacity (if SD < 0.41d)
ACCURACY USP General Chapter <41>
Tolerance Satisfactory if its weighing value is within 0.10% of the test weight value
Test weight Between 5% and 100% of the balance's capacity
Calibration uncertainty of the weight Must be ≤ 1/3 of 0.10%
Balances Requirement - USP
20. Basic principles should drive
the design of any
pharmaceutical
weighroom
Unidirectional flow of
materials and personnel
Segregation between hazardous
and non-hazardous materials
Separation of storage and
manufacturing items and spaces
21. Calibration part of OQ
Tare function
Operation of ancillary
equipment
Manually triggered or automatic
adjustment by means of built-in
weights.
– Automatic adjustment
reduce the drift of the balance
Mechanical mobility of all
moveable parts
Control of stable indication
Operational
Qualification
OQ has to cover following, but not limited to;
22. Property Definitions Acceptance
Criteria
Examples
Sensitivity
Change in weighing value divided by the
change in load, usually measured between
zero and the capacity of the balance.
NMT 0.05% deviation
where 〈41〉 is
applicable. For other
uses, respective
tolerance requirement
divided by 2.
The test load at or
sufficiently close to
the capacity of the
balance
Repeat-
ability
Ability of a weighing instrument to display
identical measurement values for repeated
weighings of the same objects under the
same conditions.
Requirement from 〈41〉
where applicable. For
other uses, user
specified requirements
will apply
10 replicate weighing's
(test weight –few
percent of the nominal
capacity of the
balance).
Performance Test
23. Performance Test
Property Definition Acceptance
Criteria
Examples
Linearity
Ability of a balance to follow the linear
relationship between a load and the
NMT 0.05% deviation where
〈41〉 is
From 3 to 6 points over
the range of the
indicated weighing value. Nonlinearity applicable. For other balance.
usually is expressed as the largest uses, respective
magnitude of any linearity deviation tolerance
within the test interval. requirement divided
by 2.
Eccentricity
Deviation in the measurement value
caused by eccentric loading—in other
NMT 0.05% deviation where
〈41〉 is
Performed in the center
of gravity & 4
words, the asymmetrical placement of applicable. For other quadrants
the center of gravity of the load relative uses, respective Test load usually
to the load receiver. Eccentricity usually tolerance should be 30% of the
is expressed as the largest magnitude of requirement divided capacity of the
any of the deviations between an off-
center reading and the center reading
by 2. balance or higher
for a given test load.
24. The accuracy is satisfactory if its
weighing value, is within 0.10% of the
test weight value
A test weight is suitable if it has a mass
between 5% and 100% of the balance's
capacity
Maximum permissible error (mpe) or
uncertinity shall 1/3 of the applied test ie
0.03%. (ASTM E617)
Accuracy <41>:
26. Perform 10 measurements with the same
reference weight
• Calculate the Standard Deviation [SD]
Repeatability is satisfactory if
– 2 x SD/Nominal reference weight used is ≤ 0.10 %
If the standard deviation obtained is less than 0.41d, (d-is the scale
interval),
replace this standard deviation with 0.41d.
–2x SD x 1000 If SD < 0.41d,
• In this case, repeatability is satisfactory if two times 0.41d, divided by
the nominal value of the weight used, does not exceed 0.10%.
– 2x SD (0.41d) x 1000 = 820d
Repeatability test <USP 41>
27. • Deviation in the measurement value caused by
eccentric loading— in other words, the asymmetrical
placement of the center of gravity of the load
• Performed in the center of gravity and the four
quadrants
• Test load usually should be 30% of the capacity of the
balance or higher.
Limit: NMT 0.05%
Deviation where (41) is applicable.
Eccentricity Test
28. It is a deviation of balance real curve from straightline joining
two points A:B – ideal weight.
Linearity test
• Linearity: To ensure that balance is accurate
at the desired level in the operating range
• Ability of a balance to follow the linear
relationship between a load and the indicated
weighing value.
• Limit: NMT 0.05% deviation where 〈41〉 is applicable. For other
uses, respective tolerance requirement divided by 2.
29. Use certified weights with an
appropriate weight class
2
Perform as performed for
repeatability test
3
Limit: NMT 0.05% deviation where
〈41〉 is applicable. For other uses,
respective tolerance requirement
divided by 2.
4
Change in weighing value divided by the
change in load, usually measured
between zero and the capacity of the
balance
1
Sensitivity Test
30. Install the balance on anti- vibration table &
Non-magnetic surface and grounded to
prevent static electricity
Room should be temperature and humidity
controlled
Vibration, air currents
Should be free of drafts and away from air
conditioner or fans or windows to avoid
strong air current or direct sunlight
Away from magnetic fields (magnetic stirrer),
electromagnetic radiation eg RF
generators/communication devices and electric
motors
Away from Corrosive materials are used
nearby.
01
02
03
04
05
06
07
LOCATION :
INSTALLATION
OF BALANCES
32. 01
02
04
03
Receivers should be
nonmagnetic used at ambient
temperature
Weighing dishes should be
polymer or aluminum.
Antistatic and compatible
with the liquid sample.
All receivers must be clean,
dry, and inert.
Weighing uncertainty for
small samples, i.e., net
weights with a mass
determined around
repeatability
Precautions while weighting
36. Tools for sampling
01
02
03
04
05
A variety of pipettes
fitted with suction bulbs,
cups or beakers, dippers
and funnels are needed.
The use of glass
should be avoided.
Liquids of low
viscosity.
should be sampled
under aseptic
conditions
Sterile
pharmaceutical
suitable inert rod
Highly viscous
liquid
a sampling tube with a
shutter at the lower end used
to sample liquids in drums
or other large containers and
a slotted tube with a pointed
end used to sample
solids.
Non-uniform
materials
spatulas or scoops
Powdered and
granular solids
37. Weighing of Volatile samples
Weighing of low boiling liquid point
in a vessel with a gas-tight
enclosure of small diameter
01
Close immediately after transfer of
material
02
After the balance display stabilizes,
the analyst records the specimen
weight
03
02
03 01
38. Aseptic or Biohazardous Samples
Weighing the samples in the confines
area / bio-safety cabinet/isolator,
or similar containment device
When materials with OELs of less than 20
µg/m3 are handled, we require the use of
transfer bottles with split butterfly valves (SBV)
and glove boxes Care should be taken if airflow in
the hood may cause balance instability
39. Sterile Weighing
A B
C D
On completion, the sterile weighing
operator will manually bring the
work-in-progress to the MAL, where
it will be picked up by the material
handler
After the weighing operations are
complete, the room must be
sanitized. Cleaning carts and mop
handles should be dedicated to the
room
A material handler will deliver the
selected materials to a material
airlock (MAL) equipped with
ultraviolet light for the sterile weigh
room (ISO 7), where
the operator will pick them up.
The operator will transfer the
materials to the weighing area
under an ISO 7 LAF, where the
materials will be weighed and
double-bagged
40. Antistatic weigh boats, antistatic guns, and antistatic screens
Placing the container in a metal holder
Balances with a built-in antistatic device is available (piezoelectric components or low amount of a
radioactive polonium) to generate a stream of ions that dissipate
How to prevent:
2
1
2
3
1
Slow drift of weighing
result
Large dispersion of
weighing results in a series
of measurements, and
No return to zero if a load
is taken off the weighing
pan
Dry, finely divided powders
may be charged with static
electricity
The static charge may
develop due to low relative
humidity, clothing worn
and gloves used
Samples with Electrostatics
Effect of electrostatic presence Possible source:
41. Magnetism as interfering factor
If magnetic load is measured,
electromagnetic field of a balance is
disturbed or weighed sample is influenced
by magnet installed in a balance
It will lead to incorrect mass reading of a
weighed sample.
High resolution balances are constructed
on basis of electromagnetic sets which
include a force-motor and magnet
01
02
03
04
How to avoid: Increasing a distance between a sample and balance mechanism. Use under-hook weighing with application
of special racks or hooks made of aluminum
43. Storage
areas
1 2 3 4
Precautions should be
taken to prevent
unauthorized persons
from entering storage
areas
Storage areas should be
of sufficient capacity to
allow the orderly storage
Storage areas should be
maintained within
acceptable temperature
limits & should be kept
clean and dry
Materials and products
should be stored off the floor
and suitably spaced to permit
ventilation, cleaning and
inspection
8 7 6 5
Narcotic products should be
stored in compliance with
international conventions,
and national laws and
regulations on narcotics
Materials and products
should be stored by
“first expired/first out”
(FEFO) principle
Materials and products
should be handled and
stored in such a manner
as to prevent
contamination, mix-ups
and cross-contamination
There should be a written
programme for pest control
and cleaning
44. Storage conditions
The storage conditions for materials and therapeutic goods s
should be in compliance with the labeling, which is based on
the results of stability testing.
Heating, ventilation and air conditioning systems (HVAC)
should be appropriately designed, installed, qualified and
maintained to ensure that the
required storage conditions are maintained
Where required, mapping studies for temperature and
relative humidity, as appropriate, should be done
01
02
03
04
04 The equipment used for monitoring should be
calibrated and be suitable for their intended use
Storage conditions for pharmaceutical products and materials should be in compliance with the
labelling, which is based on the results of stability testing
45. Labeling and
container
Receipt of incoming
materials and
pharmaceutical
products
Stock rotation and
Control
Documentation:
Written instructions
and records
Control of obsolete
and outdated materials
and pharmaceutical
product
01
04
03
02
05
Storage requirements
46. Equipments in storage area
Equipment, including
computerized
systems should be
suitable for their
intended use
If Computerized
systems are used those
should be capable of
achieving the desired
output and results.
Where electronic commerce (e-
commerce) is used, defined
procedures and adequate
systems should be in place to
ensure traceability and
confidence in the supply chain
and products concerned
Where GXP systems
are used, these
should meet the
requirements of
WHO guidelines on
computerized
systems
01 02 03 04
47. Quality Risk Management
in storage area
1 2 3 4
Simple
PowerPoint
Simple
PowerPoint
Simple
PowerPoint
Simple
PowerPoint
There should be
a system to
assess, control,
communicate
and review risks
identified at all
stages in the
supply chain
Appropriate
controls should
be developed and
implemented to
address any risks
identified
The evaluation
of the risk
should be based
on scientific
knowledge and
experience
The
effectiveness of
the controls
implemented
should be
evaluated at
periodic
intervals